Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members

Diabetes Therapy

Volumn 1, Issue 2, 2010, Pages 57-92

  Chen, Jian ^a   Williams, Sandy ^b   Ho, Samantha ^b   Loraine, Howard ^b   Hagan, Deborah ^a   Whaley, Jean M ^a   Feder, John N ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Bristol Myers Squibb R and D ^*

Author keywords

quantitative PCR; SGLT2; sodiumglucose cotransporter protein; tissue expression; type 2 diabetes

Indexed keywords

AMINO ACID TRANSPORTER; COTRANSPORTER; MESSENGER RNA; RNA; SODIUM DEPENDENT AMINO ACID TRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 2; SODIUM GLUCOSE COTRANSPORTER 4; SODIUM GLUCOSE COTRANSPORTER 5; SODIUM GLUCOSE COTRANSPORTER 6; SODIUM MYO INOSITOL COTRANSPORTER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; COLON; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE LOCATION; GENE LOCUS; GENE NUMBER; GENETIC ANALYSIS; HEART; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; LIVER; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SMALL INTESTINE; TESTIS; THYROID GLAND; TISSUE DISTRIBUTION; TRACHEA; UTERINE CERVIX;

EID: 79952721660     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-010-0006-4     Document Type: Article

References (42)

1. International Diabetes 1. Federation. Some 285 million people worldwide will live with diabetes in 2010. IDF Diabetes Atlas. Available at: http://www. diabetesatlas. org/content/some-285-million-people-worldwide-will-live-diabetes-2010. Last accessed February 3, 2010.
2. Diabetes Statistics - American Diabetes Association. Available at: http://www. diabetes. org/diabetesbasics/diabetes-statistics. Last accessed February 4, 2010.
3. Bakris GL, Fonseca VA, Sharma K, Wright EM. Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications. Kidney Int. 2009; 75: 1272-1277.
4. Bailey CJ, Gross JL, Pieters A, et al. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet. 2010; 375: 2223-2233.
5. Wright EM, Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004; 447: 510-518.
6. Hediger MA, Coady MJ, Ikeda TS, Wright EM. Expression cloning and cDNA sequencing of the Na+/glucose co-transporter. Nature. 1987; 330: 379-381.
7. Lee WS, Kanai Y, Wells RG, Hediger MA. The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression. J Biol Chem. 1994; 269: 12032-12039.
8. Martín MG, Turk E, Lostao MP, et al. Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption. Nat Genet. 1996; 12: 216-220.
9. Wells RG, Pajor AM, Kanai Y, et al. Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter. Am J Physiol. 1992; 263: F459-465.
10. Kanai Y, Lee WS, You G, et al. The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest. 1994; 93: 397-404.
11. Kong CT, Yet SF, Lever JE. Cloning and expression of a mammalian Na+/amino acid cotransporter with sequence similarity to Na+/glucose cotransporters. J Biol Chem. 1993; 268: 1509-1512.
12. Mackenzie B, Panayotova-Heiermann M, Loo DD, et al. SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation. J Biol Chem. 1994; 269: 22488-22491.
13. Diez-Sampedro A, Hirayama BA, Osswald C, et al. A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci USA. 2003; 100: 11753-11758.
14. Berry GT, Mallee JJ, Kwon HM, et al. The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. Genomics. 1995; 25: 507-513.
15. Hale CC, Rubin LJ. Ion specificity and stoichiometry of the cardiac inositol transporter. J Mol Cell Cardiol. 1995; 27: 1123-1130.
16. Tazawa S, Yamato T, Fujikura H, et al. SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1, 5-anhydro-D-glucitol, and fructose. Life Sci. 2005; 76: 1039-1050.
17. Strausberg RL, Feingold EA, Grouse LH, et al. Generation and initial analysis of more than 15, 000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA. 2002; 99: 16899-16903.
18. Roll P, Massacrier A, Pereira S, et al. New human sodium/glucose cotransporter gene (KST1): identification, characterization, and mutation analysis in ICCA (infantile convulsions and choreoathetosis) and BFIC (benign familial infantile convulsions) families. Gene. 2002; 285: 141-148.
19. Coady MJ, Wallendorff B, Gagnon DG, Lapointe J. Identification of a novel Na+/myo-inositol cotransporter. J Biol Chem. 2002; 277: 35219-35224.
20. You G, Lee WS, Barros EJ, et al. Molecular characteristics of Na(+)-coupled glucose transporters in adult and embryonic rat kidney. J Biol Chem. 1995; 270: 29365-29371.
21. Wright EM, Hirayama BA, Loo DF. Active sugar transport in health and disease. J Intern Med. 2007; 261: 32-43.
22. Zhou L, Cryan EV, D'Andrea MR, et al. Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1). J Cell Biochem. 2003; 90: 339-346.
23. Rubera I, Poujeol C, Bertin G, et al. Specific Cre/Lox recombination in the mouse proximal tubule. J Am Soc Nephrol. 2004; 15: 2050-2056.
24. Silverman M, Speight P, Ho L. Identification of two unique polypeptides from dog kidney outer cortex and outer medulla that exhibit different Na+/Dglucose cotransport functional properties. Biochim Biophys Acta. 1993; 1153: 43-52.
25. Canani RB, De Marco G, Passariello A, et al. Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells. AIDS. 2006; 20: 5-10.
26. Lahjouji K, Aouameur R, Bissonnette P, et al. Expression and functionality of the Na+/myoinositol cotransporter SMIT2 in rabbit kidney. Biochim Biophys Acta. 2007; 1768: 1154-1159.
27. Balen D, Ljubojevic M, Breljak D, et al. Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody. Am J Physiol Cell Physiol. 2008; 295: C475-489.
28. Vallon V, Platt KA, Cunard R, et al. SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol. 2010. In press.
29. Yu AS, Hirayama BA, Timbol G, et al. Functional expression of SGLTs in rat brain. Am J Physiol Cell Physiol. 2010. In press.
30. Barber RD, Harmer DW, Coleman RA, Clark BJ. GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics. 2005; 21: 389-395.
31. Human BLAT Search Genome. Available at: http://genome. ucsc. edu/cgi-bin/hgBlat?hgsid=151562971. Last accessed October 1, 2010.
32. Poppe R, Karbach U, Gambaryan S, et al. Expression of the Na+-D-glucose cotransporter SGLT1 in neurons. J Neurochem. 1997; 69: 84-94.
33. Elfeber K, Köhler A, Lutzenburg M, et al. Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier. Histochem Cell Biol. 2004; 121: 201-207.
34. Tong H, Leasure CD, Hou X, Yuen G, Briggs W, He Z. Role of root UV-B sensing in Arabidopsis early seedling development. Proc Natl Acad Sci USA. 2008; 105: 21039-21044.
35. Leasure CD, Tong H, Yuen G, Hou X, Sun X, He Z. ROOT UV-B SENSITIVE2 acts with ROOT UV-B SENSITIVE1 in a root ultraviolet B-sensing pathway. Plant Physiol. 2009; 150: 1902-1915.
36. Wu C, Orozco C, Boyer J, et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biology. 2009; 10: R130.
37. Tsai LJ, Hsiao SH, Tsai LM, et al. The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE. Tissue Antigens. 2008; 71: 114-126.
38. Han S, Hagan DL, Taylor JR, et al. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes. 2008; 57: 1723-1729.
39. Grempler R, Thomas L, Eckhardt M, et al. In vitro properties and in vivo effect on urinary glucose excretion of BI 10773, a novel selective SGLT2 inhibitor. Diabetes. 2009; 58(suppl. 1); A139.
40. Nomura S, Sakamaki S, Hongu M, et al. Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus. J Med Chem. 2010; 53: 6355-6360.
41. Kurosaki E, Tahara A, Yokono M, et al. In vitro and in vivo pharmacological properties of ASP1941: a novel, potent and selective SGLT2 inhibitor. Diabetes. 2010; 59(suppl. 1): A156.
42. Freiman J, Ruff DA, Frazier K, et al. LX4211, a dual SGLT2/SGLT1 inhibitor, shows rapid and significant improvement in glycemic control over 28 days in patients with type 2 diabetes (T2D). American Diabetes Association 2010; poster #17-LB. Available at: www. lexicon-genetics. com. Last accessed July 13, 2010.